Ovarian preservation during treatment of early stage endometrial cancer;Place de la préservation ovarienne dans le traitement des carcinomes endométriaux de stades précoces

Bulletin du Cancer

Volumn 99, Issue 1, 2012, Pages 61-68

  Poilblanc, Mathieu ^a,b   Samouelian, Vanessa ^a,c   Querleu, Denis ^b,d  

^a NOTRE DAME HOSPITAL   (Canada)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c Institut du Cancer de Montreal   (Canada)

^d ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Endometrial cancer; Lynch syndrome; Menopausal status; Ovarian preservation

Indexed keywords

AGE DISTRIBUTION; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CARDIOVASCULAR SYSTEM; EARLY CANCER; EARLY MENOPAUSE; ENDOMETRIUM CANCER; HEALTH CARE PLANNING; HORMONAL REGULATION; HUMAN; HYSTERECTOMY; OVARIAN PRESERVATION; OVARY; PROGNOSIS; QUALITY OF LIFE; REVIEW; SALPINGOOOPHORECTOMY; SKELETON; UTERUS;

EID: 84856570370     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1521     Document Type: Article

References (30)

1. Richter CE, Qian B, Martel M, et al. Ovarian preservation and staging in reproductive-age endometrial cancer patients. Gynecol Oncol 2009; 114 : 99-104.
2. Lee TS, Kim JW, Kim TJ, et al. Ovarian preservation during the surgical treatment of early stage endometrial cancer: a nation-wide study conducted by the Korean Gynecologic Oncology Group. Gynecol Oncol 2009; 115 : 26-31.
3. Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol 2009; 27 : 1214-9.
4. Cancer de l'endomètre, Collection recommandations et référentiels, INCa, Boulogne-Billancourt. Novembre 2010.
5. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 1985; 16 : 28-34. (Pubitemid 15158746)
6. Pan Z, Wang X, Zhang X, Chen X, Xie X. Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma. J Obstet Gynaecol Res 2011; 37 : 352-8.
7. Takeshima N, Hirai Y, Yano K, Tanaka N, Yamauchi K, Hasumi K. Ovarian metastasis in endometrial carcinoma. Gynecol Oncol 1998; 70 : 183-7. (Pubitemid 28430926)
8. Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP. Profile ofwomen 45 years of age and younger with endometrial cancer. Obstet Gynecol 1998; 91 : 349-54. (Pubitemid 28119833)
9. Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 2005; 106 : 693-9. (Pubitemid 41362170)
10. Gitsch G, Hanzal E, Jensen D, Hacker NF. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 1995; 85 : 504-8.
11. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60 (8 Suppl.) : 2035-41. (Pubitemid 17145924)
12. Lee TS, Jung JY, Kim JW, et al. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol 2007; 104 : 52-7. (Pubitemid 46054111)
13. Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975; 293 : 1164-7.
14. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens.NEngl J Med 1975; 293 : 1167-70.
15. Barakat RR, Bundy BN, Spirtos NM, Bell J, Mannel RS. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2006; 24 : 587-92. (Pubitemid 46630420)
16. Gambrell Jr. RD, Massey FM, Castaneda TA, Ugenas AJ, Ricci CA. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens. J Am Geriatr Soc 1979; 27 : 389-94. (Pubitemid 9251431)
17. Creasman WT, Henderson D, Hinshaw W, Clarke-Pearson DL. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 1986; 67 : 326-30. (Pubitemid 16129969)
18. Lee RB, Burke TW, Park RC. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol 1990; 36 : 189-91. (Pubitemid 20061284)
19. Chapman JA, DiSaia PJ, Osann K, Roth PD, Gillotte DL, Berman ML. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol 1996; 175 : 1195-200. (Pubitemid 26398977)
20. Audet-Walsh E, Lepine J, Gregoire J, et al. Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics. J Clin Endocrinol Metab 2011; 96 : E330-9.
21. Shuster LT, Gostout BS, Grossardt BR, Rocca WA. Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int 2008; 14 : 111-6.
22. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006; 13 : 265-79.
23. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005; 106 : 219-26. (Pubitemid 41023257)
24. Goodman A. Endometrial cancer with concurrent ovarian malignancy: assessing the risks. Obstet Gynecol 2005; 106 : 680-1. (Pubitemid 41362167)
25. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71 : 677-85. (Pubitemid 23051366)
26. Schmeler KM, Lynch HT, Chen LM, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006; 354 : 261-9. (Pubitemid 43113031)
27. Yang YC, Wu CC, Chen CP, Chang CL, Wang KL. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer. Gynecol Oncol 2005; 99 : 287-93.
28. Gotlieb WH, Beiner ME, Shalmon B, et al. Outcome of fertilitysparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 2003; 102 : 718-25. (Pubitemid 37206407)
29. Zivanovic O, Carter J, Kauff ND, Barakat RR. A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer. Gynecol Oncol 2009; 115 : 504-9.
30. Morice P, Fourchotte V, Sideris L, Gariel C, Duvillard P, Castaigne D. A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment. Gynecol Oncol 2005; 96 : 245-8. (Pubitemid 39612444)